Table of contents

Research Article

• Inhibition of xanthine oxidase by allopurinol: a therapeutic option for ischaemia induced pathological processes? (1 November, 1989)

  J G Puig, F A Mateos, V D Diaz
• Reform of the British health services: how will it affect services for people with rheumatic diseases? (1 November, 1989)

  R Grahame
• Osteoarthritis of the knee joint: an eight year prospective study. (1 November, 1989)

  L Massardo, I Watt, J Cushnaghan, P Dieppe
• Serological abnormalities, including common idiotype PR4, in families with rheumatoid arthritis. (1 November, 1989)

  P Youinou, W Williams, P Le Goff, N Tuaillon, J Jouquan, S Muller, D A Isenberg
• Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. (1 November, 1989)

  M T Walters, F K Stevenson, R Goswami, J L Smith, M I Cawley
• Localisation of lysozyme mRNA in rheumatoid synovial membrane by in situ hybridisation. (1 November, 1989)

  Y T Konttinen, V Bergroth, M Kulomaa, D Nordström, M Segerberg-Konttinen, R Keinänen, P Kemppinen, M Hukkanen, M Grönblad
• Clinical, HLA, and roentgenological follow up study of patients with juvenile arthritis: comparison between the long term outcome of transient and persistent arthritis in children. (1 November, 1989)

  H Ström, N Lindvall, B Hellström, L Rosenthal
• Ankylosing spondylitis--experience with a self administered questionnaire: an analytical study. (1 November, 1989)

  V S Ringsdal, J J Andreasen
• Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. (1 November, 1989)

  F Y Lam, W R Ferrell
• Risk factors for thrombosis in lupus patients. (1 November, 1989)

  P Hasselaar, R H Derksen, L Blokzijl, M Hessing, H K Nieuwenhuis, B N Bouma, P G De Groot
• B cell lymphokines in human systemic lupus erythematosus. (1 November, 1989)

  P L Tan, M Blumenstein, S Yeoman, J D Watson
• Liver abnormalities and liver membrane autoantibodies in systemic lupus erythematosus. (1 November, 1989)

  K Kushimoto, K Nagasawa, A Ueda, T Mayumi, Y Ishii, Y Yamauchi, Y Tada, H Tsukamoto, T Kusaba, Y Niho
• Ehlers-Danlos syndrome, clotting disorders and muscular dystrophy. (1 November, 1989)

  P Bertin, R Treves, A Julia, S Gaillard, R Desproges-Gotteron
• Osteoarthritis: the cause not result of joint failure? (1 November, 1989)

  C W Hutton
• Disease assessment in rheumatoid arthritis. (1 November, 1989)

  P L Van Riel, D M Van der Heijde, L B Van de Putte
• Phospholipase A2 and inflammation. (1 November, 1989)

  W Pruzanski, P Vadas
• Development of morphoea in rheumatoid arthritis treated with penicillamine. (1 November, 1989)

  B J Liddle
• Inflammation of the uveal tract as a presenting feature of temporal arteritis. (1 November, 1989)

  B Dasgupta, C Pitzalis, G S Panayi
• Effects of evening primrose oil in rheumatoid arthritis. (1 November, 1989)

  D F Horrobin
• Disease remission in rheumatoid arthritis. (1 November, 1989)

  A R Cabral